|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2007-12-13
|
|
pubmed:abstractText |
Gemcitabine (GEM) is efficient in treating advanced pancreatic cancer. Preliminary clinical studies showed that the efficacy of gemcitabine combined oxaliplatin (GEMOX regimen) is better than that of gemcitabine alone. But in China, the use of GEMOX regimen for advance pancreatic cancer has seldom been reported. This study was to analyze the efficacy of GEMOX regimen on advanced pancreatic cancer, and observe the adverse events.
|
|
pubmed:language |
chi
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1000-467X
|
|
pubmed:author |
pubmed-author:GuanZhong-ZhenZZ,
pubmed-author:HanBingB,
pubmed-author:HeYou-JianYJ,
pubmed-author:JiangWen-QiWQ,
pubmed-author:LiYu-HongYH,
pubmed-author:LinTong-YuTY,
pubmed-author:LuoHui-YanHY,
pubmed-author:ShiYan-XiaYX,
pubmed-author:WangFengF,
pubmed-author:XiaZhong-JunZJ,
pubmed-author:XuRui-HuaRH,
pubmed-author:ZhangLiL
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
26
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1381-4
|
|
pubmed:meshHeading |
pubmed-meshheading:18076807-Adenocarcinoma,
pubmed-meshheading:18076807-Adult,
pubmed-meshheading:18076807-Aged,
pubmed-meshheading:18076807-Anemia,
pubmed-meshheading:18076807-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:18076807-Deoxycytidine,
pubmed-meshheading:18076807-Disease-Free Survival,
pubmed-meshheading:18076807-Female,
pubmed-meshheading:18076807-Follow-Up Studies,
pubmed-meshheading:18076807-Humans,
pubmed-meshheading:18076807-Liver Neoplasms,
pubmed-meshheading:18076807-Male,
pubmed-meshheading:18076807-Middle Aged,
pubmed-meshheading:18076807-Nausea,
pubmed-meshheading:18076807-Neoplasm Staging,
pubmed-meshheading:18076807-Neutropenia,
pubmed-meshheading:18076807-Organoplatinum Compounds,
pubmed-meshheading:18076807-Pancreatic Neoplasms,
pubmed-meshheading:18076807-Remission Induction,
pubmed-meshheading:18076807-Retrospective Studies,
pubmed-meshheading:18076807-Survival Rate,
pubmed-meshheading:18076807-Thrombocytopenia,
pubmed-meshheading:18076807-Vomiting
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
[Efficacy of gemcitabine combined oxaliplatin on advanced pancreatic cancer].
|
|
pubmed:affiliation |
State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, 510060, PR China.
|
|
pubmed:publicationType |
Journal Article,
English Abstract
|
